P. Jeannin, S. Jaillon, and Y. Delneste, Pattern recognition receptors in the immune response against dying cells, Current Opinion in Immunology, vol.20, issue.5, pp.530-537, 2008.
DOI : 10.1016/j.coi.2008.04.013

O. Takeuchi and S. Akira, Pattern Recognition Receptors and Inflammation, Cell, vol.140, issue.6, pp.805-820, 2010.
DOI : 10.1016/j.cell.2010.01.022
URL : https://doi.org/10.1016/j.cell.2010.01.022

J. Savill, I. Dransfield, C. Gregory, and C. Haslett, A blast from the past: clearance of apoptotic cells regulates immune responses, Nature Reviews Immunology, vol.22, issue.12, pp.965-975, 2002.
DOI : 10.1016/S0165-6147(00)01771-5

T. Kawasaki, T. Kawai, and S. Akira, Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoimmunity, Immunological Reviews, vol.207, issue.1, pp.61-73, 2011.
DOI : 10.1084/jem.20101102

O. Ortega-hernandez, N. Bassi, Y. Shoenfeld, and J. Anaya, The Long Pentraxin 3 and Its Role in Autoimmunity, Seminars in Arthritis and Rheumatism, vol.39, issue.1, pp.38-54, 2009.
DOI : 10.1016/j.semarthrit.2008.03.006

J. Augusto, C. Onno, S. Blanchard, S. Dubuquoi, . Mantovania et al., Detection of anti-PTX3 autoantibodies in systemic lupus erythematosus, Rheumatology, vol.44, issue.4, pp.442-444, 2009.
DOI : 10.1002/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6
URL : https://academic.oup.com/rheumatology/article-pdf/48/4/442/17386257/ken507.pdf

N. Bassi, A. Ghirardello, M. Blank, S. Zampieri, P. Sarzi-puttini et al., IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus, Annals of the Rheumatic Diseases, vol.69, issue.9, pp.1704-1710, 2010.
DOI : 10.1136/ard.2009.117804

S. Bell, D. Clos, T. Khursigara, G. Picazo, J. Rubin et al., Autoantibodies to Cryptic Epitopes of C-Reactive Protein and other Acute Phase Proteins in the Toxic Oil Syndrome, Journal of Autoimmunity, vol.8, issue.2, pp.293-303, 1995.
DOI : 10.1006/jaut.1995.0022

S. Bell, H. Faust, A. Schmid, and M. Meurer, Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune diseases, Clinical and Experimental Immunology, vol.92, issue.3, pp.327-332, 1998.
DOI : 10.1073/pnas.92.3.875
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2249.1998.00655.x

M. Figueredo, A. Rodriguez, M. Ruiz-yague, M. Romero, A. Fernandez-cruz et al., Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome, J Rheumatol, vol.33, issue.10, pp.1980-1986, 2006.

B. Rosenau and P. Schur, Antibodies to C reactive protein, Annals of the Rheumatic Diseases, vol.65, issue.5, pp.674-676, 2006.
DOI : 10.1136/ard.2005.037895

Y. Shoenfeld, M. Szyper-kravitz, T. Witte, A. Doria, A. Tsutsumi et al., Autoantibodies against Protective Molecules C1q, C-Reactive Protein, Serum Amyloid P, Mannose-Binding Lectin, and Apolipoprotein A1: Prevalence in Systemic Lupus Erythematosus, Annals of the New York Academy of Sciences, vol.28, issue.1, pp.227-239, 2007.
DOI : 10.1038/ncprheum0290

A. Simon, J. Subra, P. Guilpain, P. Jeannin, P. Pignon et al., Detection of Anti-Pentraxin-3 Autoantibodies in ANCA-Associated Vasculitis, PLOS ONE, vol.24, issue.5, p.147091, 2016.
DOI : 10.1371/journal.pone.0147091.t002
URL : https://hal.archives-ouvertes.fr/inserm-01273293

C. Sjowall, A. Bengtsson, G. Sturfelt, and T. Skogh, Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus, Arthritis Research & Therapy, vol.6, issue.2, pp.87-94, 2004.
DOI : 10.1186/ar1032

C. Sjowall, A. Bengtsson, G. Sturfelt, and T. Skogh, Anti-CRP Autoantibody Levels Correlate with Disease Activity in Systemic Lupus Erythematosus, Seminars in Arthritis and Rheumatism, vol.35, issue.1, p.65, 2005.
DOI : 10.1016/j.semarthrit.2005.03.009

C. Sjowall, P. Eriksson, S. Almer, and T. Skogh, Autoantibodies to C-reactive Protein is a Common Finding in SLE, but not in Primary Sj??gren's Syndrome, Rheumatoid Arthritis or Inflammatory Bowel Disease, Journal of Autoimmunity, vol.19, issue.3, pp.155-160, 2002.
DOI : 10.1006/jaut.2002.0608

C. Sjowall, A. Zickert, T. Skogh, J. Wettero, and I. Gunnarsson, Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis, Arthritis Research & Therapy, vol.11, issue.6, p.188, 2009.
DOI : 10.1186/ar2880

Y. Tan, F. Yu, H. Yang, M. Chen, Q. Fang et al., Autoantibodies against monomeric C-reactive protein in sera from patients with lupus nephritis are associated with disease activity and renal tubulointerstitial lesions, Human Immunology, vol.69, issue.12, pp.840-844, 2008.
DOI : 10.1016/j.humimm.2008.09.006

H. Gewurz, X. Zhang, and T. Lint, Structure and function of the pentraxins, Current Opinion in Immunology, vol.7, issue.1, pp.54-64, 1995.
DOI : 10.1016/0952-7915(95)80029-8

A. Mantovani, C. Garlanda, B. Bottazzi, G. Peri, A. Doni et al., The long pentraxin PTX3 in vascular pathology, Vascular Pharmacology, vol.45, issue.5, pp.326-330, 2006.
DOI : 10.1016/j.vph.2006.08.011

L. Deban, S. Jaillon, C. Garlanda, B. Bottazzi, and A. Mantovani, Pentraxins in innate immunity: lessons from PTX3, Cell and Tissue Research, vol.5, issue.1, pp.237-249, 2011.
DOI : 10.1371/journal.ppat.0030120

D. Clos and T. , Pentraxins: Structure, Function, and Role in Inflammation, ISRN Inflammation, vol.92, issue.10, p.379040, 2013.
DOI : 10.1073/pnas.0804910105

J. Emsley, H. White, O. Hara, B. Oliva, G. Srinivasan et al., Structure of pentameric human serum amyloid P component, Nature, vol.367, issue.6461, pp.338-345, 1994.
DOI : 10.1038/367338a0

M. Pepys and G. Hirschfield, C-reactive protein: a critical update, Journal of Clinical Investigation, vol.111, issue.12, pp.1805-1812, 2003.
DOI : 10.1172/JCI200318921
URL : http://www.jci.org/articles/view/18921C1/files/pdf

A. Szalai, F. Van-ginkel, Y. Wang, J. Mcghee, and J. Volanakis, Complement-Dependent Acute-Phase Expression of C-Reactive Protein and Serum Amyloid P-Component, The Journal of Immunology, vol.165, issue.2, pp.1030-1035, 2000.
DOI : 10.4049/jimmunol.165.2.1030
URL : http://www.jimmunol.org/content/jimmunol/165/2/1030.full.pdf

C. Garlanda, B. Bottazzi, A. Bastone, and A. Mantovani, PENTRAXINS AT THE CROSSROADS BETWEEN INNATE IMMUNITY, INFLAMMATION, MATRIX DEPOSITION, AND FEMALE FERTILITY, Annual Review of Immunology, vol.23, issue.1, pp.337-366, 2005.
DOI : 10.1146/annurev.immunol.23.021704.115756

F. Breviario, E. Aniello, J. Golay, G. Peri, B. Bottazzi et al., Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to Creactive protein and serum amyloid P component, J Biol Chem, vol.267, issue.31, pp.22190-22197, 1992.

A. Inforzato, V. Rivieccio, A. Morreale, A. Bastone, A. Salustri et al., Structural Characterization of PTX3 Disulfide Bond Network and Its Multimeric Status in Cumulus Matrix Organization, Journal of Biological Chemistry, vol.33, issue.15, pp.10147-10161, 2008.
DOI : 10.1016/S0065-3233(05)70003-6
URL : http://www.jbc.org/content/283/15/10147.full.pdf

R. Latini, A. Maggioni, G. Peri, L. Gonzini, D. Lucci et al., Prognostic Significance of the Long Pentraxin PTX3 in Acute Myocardial Infarction, Circulation, vol.110, issue.16, pp.2349-2354, 2004.
DOI : 10.1161/01.CIR.0000145167.30987.2E
URL : http://circ.ahajournals.org/content/circulationaha/110/16/2349.full.pdf

B. Sjoberg, A. Qureshi, B. Anderstam, A. Alvestrand, and P. Barany, Pentraxin 3, a Sensitive Early Marker of Hemodialysis-Induced Inflammation, Blood Purification, vol.24, issue.3-4, pp.290-297, 2012.
DOI : 10.1159/000090411

B. Muller, G. Peri, A. Doni, V. Torri, R. Landmann et al., Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients, Critical Care Medicine, vol.29, issue.7, pp.1404-1407, 2001.
DOI : 10.1097/00003246-200107000-00017

A. Basile, A. Sica, E. Aniello, F. Breviario, G. Garrido et al., Journal of Biological Chemistry, vol.12, issue.13, pp.8172-8178, 1997.
DOI : 10.1073/pnas.90.21.10193

S. Jaillon, G. Peri, Y. Delneste, I. Fremaux, A. Doni et al., The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps, The Journal of Experimental Medicine, vol.65, issue.4, pp.793-804, 2007.
DOI : 10.1073/pnas.092112999
URL : http://jem.rupress.org/content/jem/204/4/793.full.pdf

K. Kessenbrock, M. Krumbholz, U. Schonermarck, W. Back, W. Gross et al., Netting neutrophils in autoimmune small-vessel vasculitis, Nature Medicine, vol.416, issue.6, pp.623-625, 2009.
DOI : 10.1016/S0002-9440(10)64532-4
URL : http://europepmc.org/articles/pmc2760083?pdf=render

D. Gershov, S. Kim, N. Brot, and K. Elkon, C-Reactive Protein Binds to Apoptotic Cells, Protects the Cells from Assembly of the Terminal Complement Components, and Sustains an Antiinflammatory Innate Immune Response, The Journal of Experimental Medicine, vol.2, issue.9, pp.1353-1364, 2000.
DOI : 10.1016/S0171-2985(98)80032-6

A. Agrawal, P. Singh, B. Bottazzi, C. Garlanda, and A. Mantovani, Pattern Recognition by Pentraxins, Adv Exp Med Biol, vol.653, pp.98-116, 2009.
DOI : 10.1007/978-1-4419-0901-5_7
URL : http://europepmc.org/articles/pmc3367411?pdf=render

J. Weiser, N. Pan, K. Mcgowan, D. Musher, A. Martin et al., Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in

C. Mold, C. Rodgers, R. Kaplan, and H. Gewurz, Binding of human C-reactive protein to bacteria, Infect Immun, vol.38, issue.1, pp.392-395, 1982.

C. De-haas, E. Van-leeuwen, T. Van-bommel, J. Verhoef, K. Van-kessel et al., Serum Amyloid P Component Bound to Gram-Negative Bacteria Prevents Lipopolysaccharide-Mediated Classical Pathway Complement Activation, Infection and Immunity, vol.68, issue.4, pp.1753-1759, 2000.
DOI : 10.1128/IAI.68.4.1753-1759.2000

M. Noursadeghi, M. Bickerstaff, J. Gallimore, J. Herbert, J. Cohen et al., Role of serum amyloid P component in bacterial infection: Protection of the host or protection of the pathogen, Proceedings of the National Academy of Sciences, vol.27, issue.7, pp.14584-14589, 2000.
DOI : 10.1002/eji.1830270712

A. Szalai, J. Vancott, J. Mcghee, J. Volanakis, B. Jr et al., Human C-Reactive Protein Is Protective against Fatal Salmonella enterica Serovar Typhimurium Infection in Transgenic Mice, Infection and Immunity, vol.68, issue.10, pp.5652-5656, 2000.
DOI : 10.1128/IAI.68.10.5652-5656.2000
URL : http://iai.asm.org/content/68/10/5652.full.pdf

A. Szalai, D. Briles, and J. Volanakis, Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice, J Immunol, vol.155, issue.5, pp.2557-2563, 1995.

A. Dias, A. Goodman, D. Santos, J. Gomes, R. Altmeyer et al., TSG-14 transgenic mice have improved survival to endotoxemia and to CLP-induced sepsis, J Leuk Biol, vol.69, issue.6, pp.928-936, 2001.

B. Han, J. Haitsma, Y. Zhang, X. Bai, M. Rubacha et al., Long pentraxin PTX3 deficiency worsens LPS-induced acute lung injury, Intensive Care Medicine, vol.108, issue.2, pp.334-342, 2011.
DOI : 10.1182/blood-2006-03-009266

A. Nauta, M. Daha, C. Van-kooten, and A. Roos, Recognition and clearance of apoptotic cells: a role for complement and pentraxins, Trends in Immunology, vol.24, issue.3, pp.148-154, 2003.
DOI : 10.1016/S1471-4906(03)00030-9

T. Griffith and T. Ferguson, Cell Death in the Maintenance and Abrogation of Tolerance: The Five Ws of Dying Cells, Immunity, vol.35, issue.4, pp.456-466, 2011.
DOI : 10.1016/j.immuni.2011.08.011

Z. Szondy, E. Garabuczi, G. Joos, G. Tsay, and Z. Sarang, Impaired Clearance of Apoptotic Cells in Chronic Inflammatory Diseases: Therapeutic Implications, Frontiers in Immunology, vol.4, issue.12, p.354, 2014.
DOI : 10.1016/j.coph.2013.05.012
URL : http://journal.frontiersin.org/article/10.3389/fimmu.2014.00354/pdf

M. Mihlan, S. Stippa, M. Jozsi, and P. Zipfel, Monomeric CRP contributes to complement control in fluid phase and on cellular surfaces and increases phagocytosis by recruiting factor H, Cell Death & Differentiation, vol.111, issue.12, pp.1630-1640, 2009.
DOI : 10.1172/JCI16651
URL : http://www.nature.com/cdd/journal/v16/n12/pdf/cdd2009103a.pdf

A. Van-rossum, F. Fazzini, P. Limburg, A. Manfredi, P. Rovere-querini et al., The prototypic tissue pentraxin PTX3, in contrast to the short pentraxin serum amyloid P, inhibits phagocytosis of late apoptotic neutrophils by macrophages, Arthritis & Rheumatism, vol.150, issue.8, pp.2667-2674, 2004.
DOI : 10.4049/jimmunol.166.11.6735

P. Baruah, I. Dumitriu, G. Peri, V. Russo, A. Mantovani et al., The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells, Journal of Leukocyte Biology, vol.80, issue.1, pp.87-95, 2006.
DOI : 10.1189/jlb.0805445

W. Rodriguez, C. Mold, L. Marnell, J. Hutt, G. Silverman et al., Prevention and reversal of nephritis in MRL/lpr mice with a single injection of C-reactive protein, Arthritis & Rheumatism, vol.389, issue.1, pp.325-335, 2006.
DOI : 10.4049/jimmunol.169.2.1058

A. Szalai, C-Reactive Protein (CRP) and Autoimmune Disease: Facts and Conjectures, Clinical and Developmental Immunology, vol.11, issue.2, pp.221-216, 2004.
DOI : 10.1080/17402520400001751
URL : http://downloads.hindawi.com/journals/jir/2004/371424.pdf

A. Szalai, C. Weaver, M. Mccrory, F. Van-ginkel, R. Reiman et al., mice expressing a human C-reactive protein transgene, Arthritis & Rheumatism, vol.4, issue.6, pp.1602-1611, 2003.
DOI : 10.1016/S1286-4579(01)01528-3
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.11026

M. Bickerstaff, M. Botto, W. Hutchinson, J. Herbert, G. Tennent et al., Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity, Nature Medicine, vol.28, issue.6, pp.694-697, 1999.
DOI : 10.1016/0022-1759(90)90380-E

J. Gillmore, W. Hutchinson, J. Herbert, A. Bybee, D. Mitchell et al., Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination?, Immunology, vol.158, issue.2, pp.255-264, 2004.
DOI : 10.1073/pnas.97.26.14584

M. Lech, C. Rommele, O. Kulkarni, H. Susanti, A. Migliorini et al., Lack of the Long Pentraxin PTX3 Promotes Autoimmune Lung Disease but not Glomerulonephritis in Murine Systemic Lupus Erythematosus, PLoS ONE, vol.55, issue.5, p.20118, 2011.
DOI : 10.1371/journal.pone.0020118.g009

N. Firooz, D. Albert, D. Wallace, M. Ishimori, D. Berel et al., High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus, Lupus, vol.45, issue.6, pp.588-597, 2011.
DOI : 10.1002/1529-0131(200008)43:8<1801::AID-ANR16>3.0.CO;2-O

L. Linares, J. Gomez-reino, P. Carreira, L. Morillas, and I. Ibero, C-reactive protein (CRP) levels in systemic lupus erythematosus (SLE), Clinical Rheumatology, vol.2, issue.1, pp.66-69, 1986.
DOI : 10.1007/BF02030970

K. Kruse, C. Janko, V. Urbonaviciute, C. Mierke, T. Winkler et al., Inefficient clearance of dying cells in patients with SLE: anti-dsDNA autoantibodies, MFG-E8, HMGB-1 and other players, Apoptosis, vol.443, issue.Pt 1, pp.1098-1113, 2010.
DOI : 10.4049/jimmunol.166.7.4498

F. Robey, K. Jones, and A. Steinberg, C-reactive protein mediates the solubilization of nuclear DNA by complement in vitro, Journal of Experimental Medicine, vol.161, issue.6, pp.1344-1356, 1985.
DOI : 10.1084/jem.161.6.1344
URL : http://jem.rupress.org/content/jem/161/6/1344.full.pdf

S. Eisenhardt, J. Thiele, H. Bannasch, G. Stark, and K. Peter, C-reactive protein: How conformational changes influence inflammatory properties, Cell Cycle, vol.8, issue.23, pp.3885-3892, 2009.
DOI : 10.4161/cc.8.23.10068
URL : http://www.tandfonline.com/doi/pdf/10.4161/cc.8.23.10068?needAccess=true

L. Potempa, J. Zeller, B. Fiedel, C. Kinoshita, and H. Gewurz, Stimulation of human neutrophils, monocytes, and platelets by modified C-reactive protein (CRP) expressing a neoantigenic specificity, Inflammation, vol.8, issue.4, pp.391-405, 1988.
DOI : 10.1007/BF00915774

M. Mosca, W. Bencivelli, C. Vitali, P. Carrai, R. Neri et al., The validity of the ECLAM index for the retrospective evaluation of disease activity in systemic lupus erythematosus, Lupus, vol.23, issue.1, pp.445-450, 2000.
DOI : 10.1002/art.1780400109

G. Zandman-goddard, M. Blank, P. Langevitz, L. Slutsky, M. Pras et al., Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity, Annals of the Rheumatic Diseases, vol.64, issue.12, pp.1698-1702, 2005.
DOI : 10.1136/ard.2005.035832

N. Bassi, D. Prete, D. Ghirardello, A. Gatto, M. Ceol et al., PTX3, Anti-PTX3, and Anti-C1q Autoantibodies in Lupus Glomerulonephritis, Clinical Reviews in Allergy & Immunology, vol.91, issue.2, pp.217-226, 2015.
DOI : 10.1111/j.1600-0412.2011.01238.x

J. Romero-diaz, D. Isenberg, and R. Ramsey-goldman, Measures of adult systemic lupus erythematosus: Updated Version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questi, Arthritis Care & Research, vol.27, issue.Suppl, pp.37-46, 2004.
DOI : 10.1002/art.1780400506
URL : http://onlinelibrary.wiley.com/doi/10.1002/acr.20572/pdf

B. Griffiths, M. Mosca, and C. Gordon, Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices, Best Practice & Research Clinical Rheumatology, vol.19, issue.5, pp.685-708, 2005.
DOI : 10.1016/j.berh.2005.03.010

J. Jennette, R. Falk, P. Hu, and H. Xiao, Pathogenesis of Antineutrophil Cytoplasmic Autoantibody???Associated Small-Vessel Vasculitis, Annual Review of Pathology: Mechanisms of Disease, vol.8, issue.1, pp.139-160, 2013.
DOI : 10.1146/annurev-pathol-011811-132453
URL : http://europepmc.org/articles/pmc5507606?pdf=render

C. Beauvillain, Y. Delneste, G. Renier, P. Jeannin, J. Subra et al., Antineutrophil Cytoplasmic Autoantibodies: How Should the Biologist Manage Them?, Clinical Reviews in Allergy & Immunology, vol.126, issue.1-2, pp.47-58, 2008.
DOI : 10.1093/ajcp/111.3.363

J. Sayegh, C. Poli, A. Chevailler, J. Subra, F. Beloncle et al., Emergency testing for antineutrophil cytoplasmic antibodies combined with a dialog-based policy between clinician and biologist: effectiveness for the diagnosis of ANCA-associated vasculitis, Internal and Emergency Medicine, vol.6, issue.Suppl 1, pp.315-319, 2015.
DOI : 10.1007/s11739-011-0667-7

C. Comarmond, C. Pagnoux, M. Khellaf, J. Cordier, M. Hamidou et al., Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort, Arthritis & Rheumatism, vol.97, issue.Suppl 52, pp.270-281, 2013.
DOI : 10.1016/j.amjcard.2005.11.088
URL : https://hal.archives-ouvertes.fr/inserm-00872767

A. Roth, J. Ooi, J. Hess, M. Van-timmeren, E. Berg et al., Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis, Journal of Clinical Investigation, vol.123, issue.4, pp.1773-1783, 2013.
DOI : 10.1172/JCI65292DS1
URL : http://www.jci.org/articles/view/65292/files/pdf

M. Talor, J. Stone, J. Stebbing, J. Barin, N. Rose et al., Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA), Clinical & Experimental Immunology, vol.7, issue.1, pp.42-48, 2007.
DOI : 10.1093/qjmed/89.4.259
URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2249.2007.03453.x/pdf

J. Knight and M. Kaplan, Lupus neutrophils, Current Opinion in Rheumatology, vol.24, issue.5, pp.441-450, 2012.
DOI : 10.1097/BOR.0b013e3283546703

J. Knight, C. Carmona-rivera, and M. Kaplan, Proteins derived from neutrophil extracellular traps may serve as self-antigens and mediate organ damage in autoimmune diseases, Frontiers in Immunology, vol.3, p.380, 2012.
DOI : 10.3389/fimmu.2012.00380
URL : http://journal.frontiersin.org/article/10.3389/fimmu.2012.00380/pdf

R. Baccala, K. Hoebe, D. Kono, B. Beutler, and A. Theofilopoulos, TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity, Nature Medicine, vol.12, issue.5, pp.543-451, 2007.
DOI : 10.4049/jimmunol.177.2.1349

P. Blanco, A. Palucka, M. Gill, V. Pascual, and J. Banchereau, Induction of Dendritic Cell Differentiation by IFN-alpha in Systemic Lupus Erythematosus, Science, vol.294, issue.5546, pp.1540-1543, 2001.
DOI : 10.1126/science.1064890

M. Denny, S. Yalavarthi, W. Zhao, S. Thacker, M. Anderson et al., A Distinct Subset of Proinflammatory Neutrophils Isolated from Patients with Systemic Lupus Erythematosus Induces Vascular Damage and Synthesizes Type I IFNs, The Journal of Immunology, vol.184, issue.6, pp.3284-3297, 2010.
DOI : 10.4049/jimmunol.0902199
URL : http://www.jimmunol.org/content/jimmunol/184/6/3284.full.pdf

E. Villanueva, S. Yalavarthi, C. Berthier, J. Hodgin, R. Khandpur et al., Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus Erythematosus, The Journal of Immunology, vol.187, issue.1, pp.538-552, 2011.
DOI : 10.4049/jimmunol.1100450
URL : http://www.jimmunol.org/content/jimmunol/187/1/538.full.pdf

R. Lande, D. Ganguly, V. Facchinetti, L. Frasca, C. Conrad et al., Neutrophils activate plasmacytoid dendritic cells by releasing self-DNApeptide complexes in systemic lupus erythematosus, Sci Transl Med, vol.3, issue.73, pp.73-92, 2011.
DOI : 10.1126/scitranslmed.3001180
URL : http://europepmc.org/articles/pmc3399524?pdf=render

G. Garcia-romo, S. Caielli, B. Vega, J. Connolly, F. Allantaz et al., Netting Neutrophils Are Major Inducers of Type I IFN Production in Pediatric Systemic Lupus Erythematosus, Science Translational Medicine, vol.10, issue.5, pp.73-93, 2011.
DOI : 10.1002/art.1780400928
URL : http://europepmc.org/articles/pmc3143837?pdf=render

S. Sangaletti, C. Tripodo, C. Chiodoni, C. Guarnotta, B. Cappetti et al., Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity, Blood, vol.120, issue.15, pp.3007-3018, 2012.
DOI : 10.1182/blood-2012-03-416156
URL : http://www.bloodjournal.org/content/bloodjournal/120/15/3007.full.pdf

S. Jaillon, P. Jeannin, Y. Hamon, I. Fremaux, A. Doni et al., Endogenous PTX3 translocates at the membrane of late apoptotic human neutrophils and is involved in their engulfment by macrophages, Cell Death & Differentiation, vol.440, issue.3, pp.465-474, 2009.
DOI : 10.1161/01.CIR.102.6.636

K. Daigo and T. Hamakubo, Host-protective effect of circulating pentraxin 3 (PTX3) and complex formation with neutrophil extracellular traps, Frontiers in Immunology, vol.3, p.378, 2012.
DOI : 10.3389/fimmu.2012.00378
URL : http://journal.frontiersin.org/article/10.3389/fimmu.2012.00378/pdf

K. Daigo, N. Yamaguchi, T. Kawamura, K. Matsubara, S. Jiang et al., The Proteomic Profile of Circulating Pentraxin 3 (PTX3) Complex in Sepsis Demonstrates the Interaction with Azurocidin 1 and Other Components of Neutrophil Extracellular Traps, Molecular & Cellular Proteomics, vol.26, issue.6, pp.111-015073, 2012.
DOI : 10.1159/000317036

Y. Tan, F. Yu, Z. Qu, T. Su, G. Xing et al., Modified C-Reactive Protein Might be a Target Autoantigen of TINU Syndrome, Clinical Journal of the American Society of Nephrology, vol.6, issue.1, pp.93-100, 2011.
DOI : 10.2215/CJN.09051209
URL : http://cjasn.asnjournals.org/content/6/1/93.full.pdf